世界の薬物乱用治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Substance Abuse Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6025 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、薬物乱用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オピオイド依存症、タバコ/ニコチン依存症、アルコール依存症）、用途別市場規模（病院・クリニック、住宅（非病院））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・薬物乱用治療薬の市場動向 ・企業の競争状況、市場シェア ・薬物乱用治療薬の種類別市場規模と予測2016-2027（オピオイド依存症、タバコ/ニコチン依存症、アルコール依存症） ・薬物乱用治療薬の用途別市場規模と予測2016-2027（病院・クリニック、住宅（非病院）） ・薬物乱用治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・薬物乱用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・薬物乱用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・薬物乱用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・薬物乱用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Indivior、Pfizer、Alkermes、Novartis、Mylan、Cipla、Glenmark、Dr. Reddy's Laboratories、Teva Pharmaceutical） ・結論

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Market Analysis and Insights: Global Substance Abuse Therapeutics Market
The global Substance Abuse Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Substance Abuse Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Substance Abuse Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Substance Abuse Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Substance Abuse Therapeutics market.

Global Substance Abuse Therapeutics Scope and Market Size
Substance Abuse Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Substance Abuse Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence

Segment by Application
Hospital & Clinics
Residential (non-hospital)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy’s Laboratories
Teva Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Substance Abuse Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Substance Abuse Therapeutics Market Perspective (2016-2027)
2.2 Substance Abuse Therapeutics Growth Trends by Regions
2.2.1 Substance Abuse Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Substance Abuse Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Substance Abuse Therapeutics Industry Dynamic
2.3.1 Substance Abuse Therapeutics Market Trends
2.3.2 Substance Abuse Therapeutics Market Drivers
2.3.3 Substance Abuse Therapeutics Market Challenges
2.3.4 Substance Abuse Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Substance Abuse Therapeutics Players by Revenue
3.1.1 Global Top Substance Abuse Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Substance Abuse Therapeutics Revenue
3.4 Global Substance Abuse Therapeutics Market Concentration Ratio
3.4.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2020
3.5 Substance Abuse Therapeutics Key Players Head office and Area Served
3.6 Key Players Substance Abuse Therapeutics Product Solution and Service
3.7 Date of Enter into Substance Abuse Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Substance Abuse Therapeutics Breakdown Data by Type
4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2022-2027)

5 Substance Abuse Therapeutics Breakdown Data by Application
5.1 Global Substance Abuse Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Substance Abuse Therapeutics Market Size (2016-2027)
6.2 North America Substance Abuse Therapeutics Market Size by Type
6.2.1 North America Substance Abuse Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Substance Abuse Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Substance Abuse Therapeutics Market Size by Type (2016-2027)
6.3 North America Substance Abuse Therapeutics Market Size by Application
6.3.1 North America Substance Abuse Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Substance Abuse Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Substance Abuse Therapeutics Market Size by Application (2016-2027)
6.4 North America Substance Abuse Therapeutics Market Size by Country
6.4.1 North America Substance Abuse Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Substance Abuse Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Substance Abuse Therapeutics Market Size (2016-2027)
7.2 Europe Substance Abuse Therapeutics Market Size by Type
7.2.1 Europe Substance Abuse Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Substance Abuse Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Substance Abuse Therapeutics Market Size by Type (2016-2027)
7.3 Europe Substance Abuse Therapeutics Market Size by Application
7.3.1 Europe Substance Abuse Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Substance Abuse Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Substance Abuse Therapeutics Market Size by Application (2016-2027)
7.4 Europe Substance Abuse Therapeutics Market Size by Country
7.4.1 Europe Substance Abuse Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Substance Abuse Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Substance Abuse Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Substance Abuse Therapeutics Market Size by Type
8.2.1 Asia-Pacific Substance Abuse Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Substance Abuse Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Substance Abuse Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Substance Abuse Therapeutics Market Size by Application
8.3.1 Asia-Pacific Substance Abuse Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Substance Abuse Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Substance Abuse Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Substance Abuse Therapeutics Market Size by Region
8.4.1 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Substance Abuse Therapeutics Market Size (2016-2027)
9.2 Latin America Substance Abuse Therapeutics Market Size by Type
9.2.1 Latin America Substance Abuse Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Substance Abuse Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Substance Abuse Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Substance Abuse Therapeutics Market Size by Application
9.3.1 Latin America Substance Abuse Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Substance Abuse Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Substance Abuse Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Substance Abuse Therapeutics Market Size by Country
9.4.1 Latin America Substance Abuse Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Substance Abuse Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Substance Abuse Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Type
10.2.1 Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Application
10.3.1 Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Substance Abuse Therapeutics Market Size by Country
10.4.1 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Details
11.1.2 Indivior Business Overview
11.1.3 Indivior Substance Abuse Therapeutics Introduction
11.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.1.5 Indivior Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Substance Abuse Therapeutics Introduction
11.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Details
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Substance Abuse Therapeutics Introduction
11.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.3.5 Alkermes Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Substance Abuse Therapeutics Introduction
11.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Substance Abuse Therapeutics Introduction
11.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Substance Abuse Therapeutics Introduction
11.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Details
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Substance Abuse Therapeutics Introduction
11.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.7.5 Glenmark Recent Development
11.8 Dr. Reddy’s Laboratories
11.8.1 Dr. Reddy’s Laboratories Company Details
11.8.2 Dr. Reddy’s Laboratories Business Overview
11.8.3 Dr. Reddy’s Laboratories Substance Abuse Therapeutics Introduction
11.8.4 Dr. Reddy’s Laboratories Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.8.5 Dr. Reddy’s Laboratories Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction
11.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Substance Abuse Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Opioid Addiction
Table 3. Key Players of Tobacco/Nicotine Addiction
Table 4. Key Players of Alcohol Dependence
Table 5. Global Substance Abuse Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Substance Abuse Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Substance Abuse Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Substance Abuse Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Substance Abuse Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Substance Abuse Therapeutics Market Share by Regions (2022-2027)
Table 11. Substance Abuse Therapeutics Market Trends
Table 12. Substance Abuse Therapeutics Market Drivers
Table 13. Substance Abuse Therapeutics Market Challenges
Table 14. Substance Abuse Therapeutics Market Restraints
Table 15. Global Substance Abuse Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Substance Abuse Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Abuse Therapeutics as of 2020)
Table 18. Ranking of Global Top Substance Abuse Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Substance Abuse Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Substance Abuse Therapeutics Product Solution and Service
Table 22. Date of Enter into Substance Abuse Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Substance Abuse Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Substance Abuse Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Substance Abuse Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Substance Abuse Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Substance Abuse Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Substance Abuse Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Substance Abuse Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Substance Abuse Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Substance Abuse Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Substance Abuse Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Substance Abuse Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Substance Abuse Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Substance Abuse Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Substance Abuse Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Substance Abuse Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Substance Abuse Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Substance Abuse Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Substance Abuse Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Substance Abuse Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Substance Abuse Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Substance Abuse Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Substance Abuse Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Substance Abuse Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Substance Abuse Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Substance Abuse Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Indivior Company Details
Table 63. Indivior Business Overview
Table 64. Indivior Substance Abuse Therapeutics Product
Table 65. Indivior Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Indivior Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Substance Abuse Therapeutics Product
Table 70. Pfizer Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Alkermes Company Details
Table 73. Alkermes Business Overview
Table 74. Alkermes Substance Abuse Therapeutics Product
Table 75. Alkermes Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Alkermes Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Substance Abuse Therapeutics Product
Table 80. Novartis Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Mylan Company Details
Table 83. Mylan Business Overview
Table 84. Mylan Substance Abuse Therapeutics Product
Table 85. Mylan Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Mylan Recent Development
Table 87. Cipla Company Details
Table 88. Cipla Business Overview
Table 89. Cipla Substance Abuse Therapeutics Product
Table 90. Cipla Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Cipla Recent Development
Table 92. Glenmark Company Details
Table 93. Glenmark Business Overview
Table 94. Glenmark Substance Abuse Therapeutics Product
Table 95. Glenmark Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Glenmark Recent Development
Table 97. Dr. Reddy's Laboratories Company Details
Table 98. Dr. Reddy's Laboratories Business Overview
Table 99. Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Dr. Reddy's Laboratories Recent Development
Table 101. Teva Pharmaceutical Company Details
Table 102. Teva Pharmaceutical Business Overview
Table 103. Teva Pharmaceutical Substance Abuse Therapeutics Product
Table 104. Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Substance Abuse Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Opioid Addiction Features
Figure 3. Tobacco/Nicotine Addiction Features
Figure 4. Alcohol Dependence Features
Figure 5. Global Substance Abuse Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital & Clinics Case Studies
Figure 7. Residential (non-hospital) Case Studies
Figure 8. Substance Abuse Therapeutics Report Years Considered
Figure 9. Global Substance Abuse Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Substance Abuse Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Substance Abuse Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Substance Abuse Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Substance Abuse Therapeutics Market Share by Players in 2020
Figure 14. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Abuse Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Substance Abuse Therapeutics Revenue in 2020
Figure 16. Global Substance Abuse Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Substance Abuse Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Substance Abuse Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Substance Abuse Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Substance Abuse Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Substance Abuse Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Substance Abuse Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Substance Abuse Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Substance Abuse Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Substance Abuse Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Substance Abuse Therapeutics Market Share by Region (2016-2027)
Figure 38. China Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Substance Abuse Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Substance Abuse Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Substance Abuse Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Substance Abuse Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Substance Abuse Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Substance Abuse Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Substance Abuse Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Indivior Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 59. Alkermes Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 61. Mylan Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 63. Glenmark Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 64. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Substance Abuse Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---